Loading...
XJPX7730
Market cap926mUSD
Jan 17, Last price  
1,469.50JPY
1D
1.70%
1Q
-15.57%
Jan 2017
58.18%
Name

Mani Inc

Chart & Performance

D1W1MN
XJPX:7730 chart
P/E
23.02
P/S
5.08
EPS
63.83
Div Yield, %
2.52%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
9.24%
Revenues
28.51b
+16.44%
7,622,197,0008,162,520,0008,790,517,0009,291,986,0009,443,774,0009,460,015,0009,693,819,0009,342,337,00011,440,135,00013,833,155,00016,555,075,00017,167,554,00020,102,760,00018,327,297,00015,200,176,00017,190,000,00020,416,000,00024,488,000,00028,513,000,000
Net income
6.29b
+5.59%
1,847,528,0002,101,084,0002,160,788,0002,156,305,0002,246,365,0002,021,116,0002,179,168,0002,180,287,0002,606,507,0002,932,876,0003,005,645,0003,315,268,0003,770,877,0006,101,796,0003,329,000,0004,291,000,0005,290,000,0005,953,000,0006,286,000,000
CFO
7.82b
-2.57%
2,192,298,0002,207,870,0002,576,500,0002,812,139,0002,861,627,0002,060,162,0002,895,436,0002,077,366,0003,417,999,0002,923,490,0003,567,846,0004,793,050,0005,569,313,0005,305,375,0001,941,506,0006,384,000,0006,559,000,0008,026,000,0007,820,000,000
Dividend
Feb 27, 20250 JPY/sh
Earnings
Apr 07, 2025

Profile

Mani, Inc. engages in the research, development, manufacture, and distribution of medical devices and dental instruments in Japan and internationally. The company offers surgical instruments, such as maniplers, vessel knives, knives, stainless wire needles, and saws used in surgical operations for incision, cutting, and suture; and ophthalmic instruments, including ophthalmic sutures and knives, and trocar kits for eye surgeries, including cataract operations. It also provides surgical eyeless and eyed needles; and dental instruments, such as endodontic instruments, endodontic rotary instruments, root canal obturation, diamond and carbide burs, finishing and polishing instruments, sutures and surgical needles, endodontic micro-accessories, and endodontic accessories. In addition, the company imports and sells medical devices. Mani, Inc. was founded in 1956 and is headquartered in Utsunomiya, Japan.
IPO date
Jun 29, 2001
Employees
3,417
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑082023‑082022‑082021‑082020‑082019‑082018‑082017‑082016‑082015‑08
Income
Revenues
28,513,000
16.44%
24,488,000
19.95%
20,416,000
18.77%
Cost of revenue
10,616,000
11,253,000
9,401,000
Unusual Expense (Income)
NOPBT
17,897,000
13,235,000
11,015,000
NOPBT Margin
62.77%
54.05%
53.95%
Operating Taxes
2,137,000
2,064,000
2,129,000
Tax Rate
11.94%
15.60%
19.33%
NOPAT
15,760,000
11,171,000
8,886,000
Net income
6,286,000
5.59%
5,953,000
12.53%
5,290,000
23.28%
Dividends
(3,646,000)
(3,149,000)
(2,362,000)
Dividend yield
1.88%
1.69%
1.37%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
41,000
87,000
Long-term debt
127,000
75,000
147,000
Deferred revenue
(129,000)
(68,000)
Other long-term liabilities
889,000
916,000
886,000
Net debt
(22,052,000)
(25,837,000)
(23,012,000)
Cash flow
Cash from operating activities
7,820,000
8,026,000
6,559,000
CAPEX
(7,681,000)
(3,720,000)
(1,944,000)
Cash from investing activities
(6,652,000)
(4,016,000)
(2,173,000)
Cash from financing activities
(3,703,000)
(3,251,000)
(2,444,000)
FCF
6,956,000
11,505,000
6,804,000
Balance
Cash
21,662,000
25,427,000
22,729,000
Long term investments
517,000
526,000
517,000
Excess cash
20,753,350
24,728,600
22,225,200
Stockholders' equity
49,211,000
51,837,000
47,502,000
Invested Capital
32,511,650
23,142,400
22,974,800
ROIC
56.64%
48.45%
40.41%
ROCE
33.60%
27.57%
24.33%
EV
Common stock shares outstanding
98,496
98,471
98,426
Price
1,966.50
3.64%
1,897.50
8.06%
1,756.00
-19.34%
Market cap
193,691,930
3.66%
186,848,722
8.11%
172,836,056
-19.34%
EV
171,639,930
161,011,722
149,824,056
EBITDA
20,167,000
15,152,000
12,760,000
EV/EBITDA
8.51
10.63
11.74
Interest
6,000
2,000
2,000
Interest/NOPBT
0.03%
0.02%
0.02%